Relpax
Product Images NDC 0049-2340

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Relpax (NDC 0049-2340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Relpax 01)

Chemical structure of the active ingredient in Relpax, showing the molecular arrangement including a sulfonyl group, indole ring, methyl group, and pyrrolidine moiety complexed with hydrobromide (HBr).*

FDA Label Image

Figure 1 (Relpax 02)

A line graph titled 'Estimated Probability of Initial Headache Response Within 2 Hours' showing response probabilities over time from 0 to 2 hours after initial dose. The graph includes curves for double blind placebo and three doses of eletriptan (20 mg, 40 mg, 80 mg), illustrating increasing response probabilities with higher doses over the time period.*

FDA Label Image

Figure 2 (Relpax 03)

A line graph titled "Estimated Probability of Taking a Second Dose/Other Medication Over the 24 Hours Following the First Dose" depicting probability on the vertical axis and time in hours from initial dose on the horizontal axis. It compares the probabilities for double blind placebo and various doses of eletriptan (20 mg, 40 mg, 80 mg) over 24 hours.*

FDA Label Image

Logo (Relpax 04)

FDA Label Image

Logo (Relpax 05)

FDA Label Image

Principal Display Panel (20 mg Tablet Blister Pack)

Packaging label for Relpax 20 mg (eletriptan HBr) tablets by Pfizer Inc. The label includes tablet removal instructions: separate along perforation, peel back paper at arrow, push tablet through foil. The image shows multiple identical labels arranged for cutting or folding, each featuring barcodes and lot and expiration placeholders.*

FDA Label Image

Principal Display Panel (20 mg Tablet Blister Pack Carton)

Relpax 20 mg (eletriptan HBr) packaging label showing a blue carton. The label includes the product name, active ingredient, and strength, with images of the round orange tablets. It specifies a package containing 6 tablets of 20 mg each. The label also displays the NDC number 0049-2330-45, manufacturer Roerig, and storage information.*

FDA Label Image

Principal Display Panel (40 mg Tablet Blister Pack)

Relpax 40 mg (eletriptan HBr) tablet packaging label by Pfizer Inc, displayed as multiple individual tablet sections with instructions to remove tablets by separating along perforations, peeling back paper, and pushing the tablet through the foil. The label includes barcode, lot number placeholder, expiration date placeholder, and manufacturer information.*

FDA Label Image

Principal Display Panel (40 mg Tablet Blister Pack Carton)

Relpax 40 mg (eletriptan HBr) packaging label showing a card containing 6 tablets. The label displays the product name, active ingredient, strength, and pill image with imprint "RELPAX". The labeler is Roerig, a division of Pfizer. Storage and dosage information is included along with NDC 0049-2340-45. The product is made in Ireland and marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.